Who should avoid TRE
Time-restricted eating is a mild intervention for a healthy adult — and the wrong tool for a specific list of people. This page draws that line: the groups where the evidence, or the absence of it, argues against fasting, the medications that interact, and the red flags that mean you should stop.
What the evidence supports
- Fasting raises hypoglycemia risk in people taking insulin or sulfonylureas — the clinical guidance literature is explicit (Nutrients, 2019).
- Intermittent-fasting engagement is associated with eating-disorder psychopathology in adolescents and young adults (Eating Behaviors, 2022).
- Very-low-calorie regimens carry a measurable gallstone risk — roughly a quarter of participants in a landmark trial (NEJM, 1988).
What remains uncertain
- Effects of TRE in pregnancy — no trials exist, and none should; the default is avoidance.
- Whether fasting in people with treated diabetes is safe long-term — trials are small and short.
- Where the safe line sits for people in recovery from eating disorders — the restriction framing itself is the concern.
Evidence last reviewed: August 15, 2026. Conclusions may change as new research is published.
the safety filter
The Short Version
Four groups should simply not fast, and a fifth needs supervision. Skip time-restricted eating entirely if you are pregnant or breastfeeding, have a history of an eating disorder, are underweight or a frail older adult, or are still growing. Approach it only with medical oversight if you take glucose-lowering medications — insulin and sulfonylureas in particular — or manage a chronic condition where meal timing and medication timing interact. Everything else on this page explains the reasoning, and the Fasting Protocol's who-shouldn't page owns the hormonal detail.
Pregnancy & Breastfeeding
The case here is not a study; it is the absence of one. No randomized trial has tested time-restricted eating in pregnancy, and no ethics committee would approve one — the stakes are asymmetric, and the potential benefit is a diet tweak. What exists is physiology and caution: pregnancy raises energy and nutrient demand (protein, iron, folate, choline) at the exact moment that a compressed window makes those targets harder to hit, and fasting shifts insulin and cortisol in ways the body's pregnant state was not designed around. Breastfeeding adds a continuous energy cost of roughly five hundred calories a day. The clinical default, and this site's, is plain: eating regularly through the day is the evidence-appropriate choice, and any fasting plan during pregnancy belongs in a clinician's office, not a protocol page.
Eating-Disorder History
Fasting is restriction with a schedule, and restriction is the one thing a recovering brain does not need practice at. The signal in the data is cautionary: in a 2022 study of Canadian adolescents and young adults, intermittent-fasting engagement was associated with greater eating-disorder psychopathology (Eating Behaviors, 2022) — the direction runs through compulsive exercise and compensatory behavior patterns that fasting's rule structure can quietly feed. The association does not prove fasting causes relapse, and for some people a stable routine genuinely helps. But the risk profile is asymmetric: the cost of a relapse is high, the benefit of a narrower eating window is modest, and the honest default is to avoid time-restricted eating after an eating-disorder history — or, at minimum, to make that decision with the clinician who knows your history, never from a fasting app.
Medications & Chronic Conditions
The medication interaction that matters most is hypoglycemia. Insulin and sulfonylureas lower blood glucose on their own schedule, and a skipped meal or a compressed window can drop it further — the clinical guidance literature on fasting in diabetes is explicit that these regimens demand supervision and usually medication adjustment (Nutrients, 2019). Other medications interact more quietly but still matter: SGLT2 inhibitors can predispose to dehydration and ketosis when intake drops, blood-pressure medications can overshoot when fasting lowers pressure (early TRE trials measured exactly that), and levothyroxine wants an empty stomach and consistent timing — the kind of detail that fasting changes without asking. Chronic conditions add their own variables: gallstone risk climbs with rapid weight loss, as a landmark trial showed — roughly a quarter of participants on very-low-calorie diets developed gallstones (NEJM, 1988) — and anyone with a history of gout, reflux, or migraine should expect their condition to weigh in on schedule changes. This is clinician territory, not protocol territory: if you take daily medication, the question "can I fast?" is answered in a consultation, not a comment section.
Underweight Adults, Frail Older Adults, & Growing Bodies
The groups fasting serves least are the ones least represented in its trials — and the reasoning runs on first principles. Underweight adults need more calories, and a window that suppresses intake works against them by definition. Frail older adults face the sharpest version of the problem: appetite is already falling, protein needs are already rising with age, and every skipped meal is lean mass not replaced — fasting solves a problem this group does not have. Children and adolescents are growing on schedules that fasting has never been tested against, and the eating-disorder signal in young people (above) argues for caution with restriction framing during the years identity and food rules get built. The through-line: fasting is a tool for metabolically overfed adults with weight to lose. Outside that population, the risk-benefit equation flips quickly.
⚠️ Clinician territory
If you take insulin, sulfonylureas, or any medication whose timing interacts with meals — or if you are pregnant, underweight, in eating-disorder recovery, or managing a chronic condition — fasting decisions stop being self-serve. Bring the protocol to your clinician and let them adapt it; nothing on this site prescribes, and this corner of the evidence base is exactly where prescribing by internet is most dangerous.
| Group | Why caution | Guidance |
|---|---|---|
| 🤰 Pregnancy & breastfeeding | Rising energy and nutrient demands; zero trials, asymmetric stakes | Avoid |
| 🧠 Eating-disorder history | Restriction framing associated with ED psychopathology (Eating Behaviors, 2022) | Avoid |
| 💉 Insulin / sulfonylureas | Hypoglycemia risk; needs medication adjustment (Nutrients, 2019) | Medical supervision |
| 🩸 SGLT2 inhibitors, BP meds, levothyroxine | Dehydration, overshooting pressure, and empty-stomach timing interactions | Ask clinician |
| ⚖️ Underweight / frail older adults | Energy and protein needs already unmet; lean mass at stake | Caution |
| 🧒 Children & adolescents | Growth demands; restriction framing in identity-forming years | Generally avoid |
Red Flags Once You're In
If you are in the population fasting is meant for, watch for the signals that it is not working for you specifically — they matter more than any trial average:
- 😵 Dizziness, cold hands, or light-headedness beyond the first week — the window may be too narrow, or calories too low inside it.
- 🌙 Sleep that gets worse, not better — late dinner windows are the usual cause; shift the window earlier before quitting.
- 🌊 Menstrual changes in any direction — the hormonal data are thin, and cycle disruption is a stop signal, not a badge of commitment.
- 🍩 Rebound binges when the window opens — the restriction is too tight for you; widening the window is the fix, not more discipline.
- 📉 Weight or strength trending down unintentionally — check protein and total calories before blaming anything else.
- 🧠 Obsessive clock-watching — when the window becomes a rule you police rather than a rhythm you keep, it has stopped being a health tool.
A Gatekeeper Checklist Before Starting
- ✅ Not pregnant, not breastfeeding, no eating-disorder history. Any yes here: do not fast.
- ✅ Medication list reviewed. Nothing glucose-lowering without a clinician's sign-off; nothing that needs food or specific timing without a plan.
- ✅ Weight status appropriate. Not underweight, not a frail older adult, not still growing.
- ✅ A reason that fits the tool. Late-night eating or an excess of eating occasions — the problems TRE actually solves (window-dose page).
- ✅ A protein plan inside the window. The muscle page's arithmetic, done before day one.
- ✅ An exit criterion agreed in advance. The red flags above, written down — a protocol you cannot leave is a diet wearing a costume.
Questions, Answered Briefly
- 👩 Can women fast safely? Most women can, gently — 12–14 hour windows, watching for cycle and sleep changes. The protocol's who-shouldn't page covers the hormonal evidence honestly, including its thinness.
- 💊 I take metformin. Is fasting fine? Metformin is lower-risk than insulin or sulfonylureas, but it is still glucose-lowering — the honest answer is a clinician conversation, not a general rule.
- 🦴 Does fasting hurt bone health? The data are too thin for a verdict; rapid weight loss is the clearer bone risk, especially after menopause. If bone density is a concern, gentle windows and resistance training are the sensible pairing.
- 🌡️ I felt great fasting but then hit a wall. Normal? Common — the first weeks are an adaptation, and a wall later often means the window has become too aggressive for your current training or stress load. Widen before you quit.
The Bottom Line
- Do not fast: pregnancy, breastfeeding, eating-disorder history, underweight or frail older adults, growing bodies. The evidence, or its absence, is clear.
- Glucose-lowering medications change the question entirely — insulin and sulfonylureas mean clinician supervision, no exceptions.
- Red flags are stop signals, not failure notices: dizziness, cycle changes, rebound binges, worsening sleep.
- Fasting is a tool for metabolically overfed adults with a matching problem. Outside that population, the risk-benefit equation flips — and knowing when not to use a tool is half of using it well.
Related Topics
- Grajower & Horne, "Clinical management of intermittent fasting in patients with diabetes mellitus," Nutrients (2019)
- Ganson et al., "Intermittent fasting: describing engagement and associations with eating disorder behaviors and psychopathology among Canadian adolescents and young adults," Eating Behaviors (2022)
- Broomfield et al., "Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight," New England Journal of Medicine (1988)
- Corley et al., "Intermittent fasting in type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial," Diabetic Medicine (2018)
- Trepanowski & Bloomer, "The impact of religious fasting on human health," Nutrition Journal (2010)
- Heilbronn et al., "Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism," American Journal of Clinical Nutrition (2005)